Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03139357 · ClinicalTrials.gov registry record
Behavioral Monitoring in Primary Care
A clinical trial, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- 11
- Enrollment target
NCT03139357: Clinical Trial study, sponsored by University of Pittsburgh.
NCT03139357 is a clinical trial that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03139357 was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Stress and anxiety can worsen quality of life in patients seen in primary care practices. Patients at predetermined practices age 20-65 receive psychosocial screening instruments for anxiety and quality of life (GAD7 and SF-12) at six month intervals for twenty-four months as part of routine care. Assessing anxiety and quality of life every six months will provide data to analyze whether anxiety and quality of life changes over time. Patients who consent will also be asked at 6, 12, 18, and 24 months about medical utilization of behavioral care or any medical care outside of University of Pittsburgh Medical Center in order to be part of their research record for good clinical care. If patients received any behavioral treatment, the patient will also be asked questions regarding the helpfulness of this treatment. This is an observational characterization study to understand the psychiatric and behavioral needs of primary care patients. The follow-up questionnaires and medical record information will look at the rates and predictors of hospitalizations and/ or behavioral health treatment as a longitudinal way to track these symptoms over time. These resources are critical to determine the need for embedded behavioral care in primary care settings.
Primary Outcome
mesures anxiety
Interventions
- OTHER GAD7, SF12, medical utilization, helpfulness questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-12-22 |
| Est. Completion | 2017-03-07 |
Why NCT03139357 stopped before completion
NCT03139357 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which GAD7, SF12, medical utilization, helpfulness questionnaire is the first listed.
NCT03139357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03139357 about?
NCT03139357 is a clinical study titled "Behavioral Monitoring in Primary Care". Stress and anxiety can worsen quality of life in patients seen in primary care practices. Patients at predetermined practices age 20-65 receive psychosocial screening instruments for anxiety and quality of life (GAD7 and SF-12) at six month intervals for twenty-four months as part of routine care. A...
What is the current status of trial NCT03139357?
This trial is currently terminated. The enrollment target is 11 participants. The study started on 2016-12-22. Estimated completion is 2017-03-07.
What interventions are being tested in trial NCT03139357?
The interventions under investigation include: GAD7, SF12, medical utilization, helpfulness questionnaire (OTHER).
Who is sponsoring clinical trial NCT03139357?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI